Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MKC-1 in Recurrent/Resistant Ovarian or Endometrial Cancer
NCT00607607Phase 2Completed
- Sponsor
- CASI Pharmaceuticals, Inc.
- Start
- Jan 2008
- Primary completion
- Jun 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of mkc-1 in ovarian cancer, endometrial cancer (EC), sponsored by CASI Pharmaceuticals, Inc.. Started Jan 2008; status: completed.
02
Drugs
mkc-1
03
Conditions
ovarian cancerendometrial cancer (EC)
Beyond the preview
Go deeper on NCT00607607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00607607.